A closer look at the World Health Organization’s prescribing indicators Richard Ofori‑Asenso

ABSTRACT

This communication focuses on the World Health Organization’s prescribing indicators. It describes the methods for computing the indicators and highlights their applicability as well as limitations in evaluating the patterns of medicines usage.

KEYWORDS

• Drug use indicators
• pharmacoepidemiology
• prescribing indicators

Showing references and in-text citations exactly as published.

Cite this article

• DOI10.4103/0976-500X.179352Copy

RELATED ARTICLES

Matched on section and article type within this issue of J Pharmacol. Pharmacother..

• Article · VOLUME 7, ISSUE 1Abuse of topical corticosteroids in India: Concerns and the way forwardSubodh Kumar, Aman Goyal, Yogendra Kumar Gupta · pp. 1–2Same type: Article
• Article · VOLUME 7, ISSUE 1Variability in plasma concentration of cefotaxime in critically ill patients in an Intensive Care Unit of India and its pharmacodynamic outcome: A nonrandomized, prospective, open‑label, analytical studyB. Abhilash, Chakra Dhar Tripathi, Anoop Raj Gogia, Girish Gulab Meshram, Manu Kumar, B. Suraj · pp. 15–21Same type: Article
• Article · VOLUME 7, ISSUE 1Inhibition of astrocyte activation is involved in the prevention of postoperative latent pain sensitization by ketamine and gabapentin in miceElizabeth Romero-Alejo, Margarita M. Puig, Asunción Romero · pp. 22–4Same type: Article
• Article · VOLUME 7, ISSUE 1Nonsteroidal anti-inflammatory drugs causing local inflammation of tissue at the site of injectionAnton Aleksandrovich Kasatkin, Alexandr A. Urakov, Ilya Aleksandrovich Lukoyanov · pp. 26–8Same type: Article